Mulligan H D, Beck S A, Tisdale M J
CRC Experimental Chemotherapy Group, Pharmaceutical Sciences Institute, Aston University, Birmingham, UK.
Br J Cancer. 1992 Jul;66(1):57-61. doi: 10.1038/bjc.1992.216.
The effect of cancer cachexia on the oxidative metabolism of lipids has been studied in mice transplanted either with the MAC16 adenocarcinoma, which induces profound loss of body weight and depletion of lipid stores, or the MAC13 adenocarcinoma, which is the same histological type, but which grows without an effect on host body weight or lipid stores. While oxidation of D-[U-14C]glucose did not differ between animals bearing tumours of either type and non-tumour bearing controls, oxidation of [1-14C]triolein administered by intragastric intubation was significantly (P less than 0.05) higher in animals bearing the MAC16 tumour than in either non tumour-bearing controls or in animals bearing the MAC13 tumour. Intestinal absorption of [14C]lipid was significantly (P less than 0.05) reduced in animals bearing the MAC13 tumour when compared with either non tumour-bearing animals or MAC16 tumour-bearing animals, but was not significantly different in the latter two groups. The level of labelled lipids in heart and adipose tissue after an oral [14C]lipid load was significantly lower in animals bearing the MAC16 tumour compared with the other two groups. The level of tumour lipids was also higher in the MAC16 than in the MAC13 tumour after both an oral [14C]lipid load or by direct injection of [U-14C]palmitate complexed to albumin into epididymal fat pads. Oxidation of [U-14C]palmitate was also significantly enhanced in liver and heart homogenates from animals bearing the MAC16 tumour. These results suggest that in cachectic tumour-bearing animals mobilisation of body lipids is accompanied by an increased utilisation.
癌症恶病质对脂质氧化代谢的影响已在移植了MAC16腺癌或MAC13腺癌的小鼠中进行了研究。MAC16腺癌可导致体重显著下降和脂质储备消耗,而MAC13腺癌与MAC16腺癌组织学类型相同,但生长时对宿主体重或脂质储备无影响。虽然D-[U-14C]葡萄糖的氧化在携带这两种肿瘤类型的动物与未携带肿瘤的对照动物之间没有差异,但通过胃内插管给予的[1-14C]甘油三酯的氧化在携带MAC16肿瘤的动物中显著(P<0.05)高于未携带肿瘤的对照动物或携带MAC13肿瘤的动物。与未携带肿瘤的动物或携带MAC16肿瘤的动物相比,携带MAC13肿瘤的动物中[14C]脂质的肠道吸收显著(P<0.05)降低,但后两组之间没有显著差异。口服[14C]脂质负荷后,携带MAC16肿瘤的动物心脏和脂肪组织中标记脂质的水平显著低于其他两组。口服[14C]脂质负荷或通过将与白蛋白复合的[U-14C]棕榈酸酯直接注射到附睾脂肪垫后,MAC16肿瘤中的肿瘤脂质水平也高于MAC13肿瘤。来自携带MAC16肿瘤的动物的肝脏和心脏匀浆中[U-14C]棕榈酸酯的氧化也显著增强。这些结果表明,在患有恶病质的荷瘤动物中,身体脂质的动员伴随着利用率的增加。